Heron Therapeutics, Inc. (HRTX) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
14/25
Growth 4
Margin 2
Expansion 4
Platform 2
Financial 2
latest quarter score
Earnings Reports
- 14
- 20
- 16
- 16